Published November 14, 2017
Donald Mager, ’91, ’00 & ’02, professor and vice-chair, pharmaceutical sciences, received the 2017 International Society of Pharmacometrics (ISoP) Innovation Award and was named a Fellow of ISoP at the 8 annual American Conference on Pharmacometrics meeting in Fort Lauderdale, FL.
The ISoP Innovation Award acknowledges individuals whose scientific and innovative contributions have advanced the field of pharmacometrics. ISoP fellows demonstrate significant and sustained contributions to the promotion and advancement of pharmacometrics. Both recognitions embody the mission of ISoP: to broaden the impact of pharmacometrics.
Mager was also named a Fellow of the American Association of Pharmaceutical Scientists (AAPS), one of the highest honors given to members of the association, at the AAPS annual meeting in San Diego, CA.
Each year, AAPS elevates select members to Fellow in recognition of their professional excellence in fields relevant to its mission: to advance the capacity of pharmaceutical scientists to develop products and therapies that improve global health. Fellows are nominated by supporters, selected by a committee of their peers, and elevated by the AAPS Executive Council.
The American Association of Pharmaceutical Scientists is a professional, scientific organization of approximately 9,000 members employed in academia, industry, government, and other research institutes worldwide.
Mager has mentored 30 graduate students, 11 post-doctoral fellows, 2 visiting scientists, and 4 undergraduate students. His research has made major contributions to structure-activity relationships in PK/PD, creating new theoretical concepts and applications related to target-mediated drug disposition, assessing properties of antibody-based therapeutics, developing cancer chemotherapy models, and evolving increasingly complex systems pharmacology models. His work is an example of the creative incorporation of mechanistically inspired computational modeling to provide a more robust framework for understanding drug action.